ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pulmonary Embolism Therapeutics Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-37B13657
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Pulmonary Embolism Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Pulmonary Embolism Therapeutics Market Research Report 2025

Code: QYRE-Auto-37B13657
Report
July 2025
Pages:68
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Boehringer Ingelheim International
Bristol–Myers Squibb
Daiichi Sankyo
F.Hoffmann-La Roche
Johnson & Johnson

The global market for Pulmonary Embolism Therapeutics was valued at US$ 2754 million in the year 2024 and is projected to reach a revised size of US$ 4994 million by 2031, growing at a CAGR of 9.0% during the forecast period.

Pulmonary Embolism Therapeutics Market

Pulmonary Embolism Therapeutics Market

Lifestyle associated factors such as smoking, overweight, old-age pregnancy, and excessive use of estrogen supplements are some of the major causes of pulmonary embolism.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pulmonary Embolism Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pulmonary Embolism Therapeutics.
The Pulmonary Embolism Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pulmonary Embolism Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pulmonary Embolism Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pulmonary Embolism Therapeutics Market Report

Report Metric Details
Report Name Pulmonary Embolism Therapeutics Market
Accounted market size in year US$ 2754 million
Forecasted market size in 2031 US$ 4994 million
CAGR 9.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Adult
  • Child
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Boehringer Ingelheim International, Bristol-Myers Squibb, Daiichi Sankyo, F. Hoffmann-La Roche, Johnson & Johnson
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pulmonary Embolism Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pulmonary Embolism Therapeutics Market growing?

Ans: The Pulmonary Embolism Therapeutics Market witnessing a CAGR of 9.0% during the forecast period 2025-2031.

What is the Pulmonary Embolism Therapeutics Market size in 2031?

Ans: The Pulmonary Embolism Therapeutics Market size in 2031 will be US$ 4994 million.

Who are the main players in the Pulmonary Embolism Therapeutics Market report?

Ans: The main players in the Pulmonary Embolism Therapeutics Market are Boehringer Ingelheim International, Bristol-Myers Squibb, Daiichi Sankyo, F. Hoffmann-La Roche, Johnson & Johnson

What are the Application segmentation covered in the Pulmonary Embolism Therapeutics Market report?

Ans: The Applications covered in the Pulmonary Embolism Therapeutics Market report are Adult, Child

What are the Type segmentation covered in the Pulmonary Embolism Therapeutics Market report?

Ans: The Types covered in the Pulmonary Embolism Therapeutics Market report are Oral, Parenteral

Recommended Reports

Pulmonary Disorders

Cardiovascular Therapies

Thrombotic and Embolic

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pulmonary Embolism Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Parenteral
1.3 Market by Application
1.3.1 Global Pulmonary Embolism Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Adult
1.3.3 Child
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pulmonary Embolism Therapeutics Market Perspective (2020-2031)
2.2 Global Pulmonary Embolism Therapeutics Growth Trends by Region
2.2.1 Global Pulmonary Embolism Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pulmonary Embolism Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Pulmonary Embolism Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Pulmonary Embolism Therapeutics Market Dynamics
2.3.1 Pulmonary Embolism Therapeutics Industry Trends
2.3.2 Pulmonary Embolism Therapeutics Market Drivers
2.3.3 Pulmonary Embolism Therapeutics Market Challenges
2.3.4 Pulmonary Embolism Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pulmonary Embolism Therapeutics Players by Revenue
3.1.1 Global Top Pulmonary Embolism Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Pulmonary Embolism Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Pulmonary Embolism Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pulmonary Embolism Therapeutics Revenue
3.4 Global Pulmonary Embolism Therapeutics Market Concentration Ratio
3.4.1 Global Pulmonary Embolism Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pulmonary Embolism Therapeutics Revenue in 2024
3.5 Global Key Players of Pulmonary Embolism Therapeutics Head office and Area Served
3.6 Global Key Players of Pulmonary Embolism Therapeutics, Product and Application
3.7 Global Key Players of Pulmonary Embolism Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pulmonary Embolism Therapeutics Breakdown Data by Type
4.1 Global Pulmonary Embolism Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Pulmonary Embolism Therapeutics Forecasted Market Size by Type (2026-2031)
5 Pulmonary Embolism Therapeutics Breakdown Data by Application
5.1 Global Pulmonary Embolism Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Pulmonary Embolism Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pulmonary Embolism Therapeutics Market Size (2020-2031)
6.2 North America Pulmonary Embolism Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pulmonary Embolism Therapeutics Market Size by Country (2020-2025)
6.4 North America Pulmonary Embolism Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pulmonary Embolism Therapeutics Market Size (2020-2031)
7.2 Europe Pulmonary Embolism Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pulmonary Embolism Therapeutics Market Size by Country (2020-2025)
7.4 Europe Pulmonary Embolism Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pulmonary Embolism Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Pulmonary Embolism Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pulmonary Embolism Therapeutics Market Size (2020-2031)
9.2 Latin America Pulmonary Embolism Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pulmonary Embolism Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Pulmonary Embolism Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pulmonary Embolism Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Pulmonary Embolism Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim International
11.1.1 Boehringer Ingelheim International Company Details
11.1.2 Boehringer Ingelheim International Business Overview
11.1.3 Boehringer Ingelheim International Pulmonary Embolism Therapeutics Introduction
11.1.4 Boehringer Ingelheim International Revenue in Pulmonary Embolism Therapeutics Business (2020-2025)
11.1.5 Boehringer Ingelheim International Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Pulmonary Embolism Therapeutics Introduction
11.2.4 Bristol-Myers Squibb Revenue in Pulmonary Embolism Therapeutics Business (2020-2025)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Daiichi Sankyo
11.3.1 Daiichi Sankyo Company Details
11.3.2 Daiichi Sankyo Business Overview
11.3.3 Daiichi Sankyo Pulmonary Embolism Therapeutics Introduction
11.3.4 Daiichi Sankyo Revenue in Pulmonary Embolism Therapeutics Business (2020-2025)
11.3.5 Daiichi Sankyo Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Details
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Pulmonary Embolism Therapeutics Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Pulmonary Embolism Therapeutics Business (2020-2025)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Pulmonary Embolism Therapeutics Introduction
11.5.4 Johnson & Johnson Revenue in Pulmonary Embolism Therapeutics Business (2020-2025)
11.5.5 Johnson & Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Boehringer Ingelheim International
Bristol–Myers Squibb
Daiichi Sankyo
F.Hoffmann-La Roche
Johnson & Johnson
List of Tables
 Table 1. Global Pulmonary Embolism Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Oral
 Table 3. Key Players of Parenteral
 Table 4. Global Pulmonary Embolism Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Pulmonary Embolism Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pulmonary Embolism Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Pulmonary Embolism Therapeutics Market Share by Region (2020-2025)
 Table 8. Global Pulmonary Embolism Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Pulmonary Embolism Therapeutics Market Share by Region (2026-2031)
 Table 10. Pulmonary Embolism Therapeutics Market Trends
 Table 11. Pulmonary Embolism Therapeutics Market Drivers
 Table 12. Pulmonary Embolism Therapeutics Market Challenges
 Table 13. Pulmonary Embolism Therapeutics Market Restraints
 Table 14. Global Pulmonary Embolism Therapeutics Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Pulmonary Embolism Therapeutics Market Share by Players (2020-2025)
 Table 16. Global Top Pulmonary Embolism Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Embolism Therapeutics as of 2024)
 Table 17. Ranking of Global Top Pulmonary Embolism Therapeutics Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Pulmonary Embolism Therapeutics Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Pulmonary Embolism Therapeutics, Headquarters and Area Served
 Table 20. Global Key Players of Pulmonary Embolism Therapeutics, Product and Application
 Table 21. Global Key Players of Pulmonary Embolism Therapeutics, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Pulmonary Embolism Therapeutics Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Pulmonary Embolism Therapeutics Revenue Market Share by Type (2020-2025)
 Table 25. Global Pulmonary Embolism Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Pulmonary Embolism Therapeutics Revenue Market Share by Type (2026-2031)
 Table 27. Global Pulmonary Embolism Therapeutics Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Pulmonary Embolism Therapeutics Revenue Market Share by Application (2020-2025)
 Table 29. Global Pulmonary Embolism Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Pulmonary Embolism Therapeutics Revenue Market Share by Application (2026-2031)
 Table 31. North America Pulmonary Embolism Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Pulmonary Embolism Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Pulmonary Embolism Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Pulmonary Embolism Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Pulmonary Embolism Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Pulmonary Embolism Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Pulmonary Embolism Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pulmonary Embolism Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Pulmonary Embolism Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Pulmonary Embolism Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Pulmonary Embolism Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Boehringer Ingelheim International Company Details
 Table 47. Boehringer Ingelheim International Business Overview
 Table 48. Boehringer Ingelheim International Pulmonary Embolism Therapeutics Product
 Table 49. Boehringer Ingelheim International Revenue in Pulmonary Embolism Therapeutics Business (2020-2025) & (US$ Million)
 Table 50. Boehringer Ingelheim International Recent Development
 Table 51. Bristol-Myers Squibb Company Details
 Table 52. Bristol-Myers Squibb Business Overview
 Table 53. Bristol-Myers Squibb Pulmonary Embolism Therapeutics Product
 Table 54. Bristol-Myers Squibb Revenue in Pulmonary Embolism Therapeutics Business (2020-2025) & (US$ Million)
 Table 55. Bristol-Myers Squibb Recent Development
 Table 56. Daiichi Sankyo Company Details
 Table 57. Daiichi Sankyo Business Overview
 Table 58. Daiichi Sankyo Pulmonary Embolism Therapeutics Product
 Table 59. Daiichi Sankyo Revenue in Pulmonary Embolism Therapeutics Business (2020-2025) & (US$ Million)
 Table 60. Daiichi Sankyo Recent Development
 Table 61. F. Hoffmann-La Roche Company Details
 Table 62. F. Hoffmann-La Roche Business Overview
 Table 63. F. Hoffmann-La Roche Pulmonary Embolism Therapeutics Product
 Table 64. F. Hoffmann-La Roche Revenue in Pulmonary Embolism Therapeutics Business (2020-2025) & (US$ Million)
 Table 65. F. Hoffmann-La Roche Recent Development
 Table 66. Johnson & Johnson Company Details
 Table 67. Johnson & Johnson Business Overview
 Table 68. Johnson & Johnson Pulmonary Embolism Therapeutics Product
 Table 69. Johnson & Johnson Revenue in Pulmonary Embolism Therapeutics Business (2020-2025) & (US$ Million)
 Table 70. Johnson & Johnson Recent Development
 Table 71. Research Programs/Design for This Report
 Table 72. Key Data Information from Secondary Sources
 Table 73. Key Data Information from Primary Sources
 Table 74. Authors List of This Report


List of Figures
 Figure 1. Pulmonary Embolism Therapeutics Picture
 Figure 2. Global Pulmonary Embolism Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pulmonary Embolism Therapeutics Market Share by Type: 2024 VS 2031
 Figure 4. Oral Features
 Figure 5. Parenteral Features
 Figure 6. Global Pulmonary Embolism Therapeutics Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pulmonary Embolism Therapeutics Market Share by Application: 2024 VS 2031
 Figure 8. Adult Case Studies
 Figure 9. Child Case Studies
 Figure 10. Pulmonary Embolism Therapeutics Report Years Considered
 Figure 11. Global Pulmonary Embolism Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Pulmonary Embolism Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Pulmonary Embolism Therapeutics Market Share by Region: 2024 VS 2031
 Figure 14. Global Pulmonary Embolism Therapeutics Market Share by Players in 2024
 Figure 15. Global Top Pulmonary Embolism Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Embolism Therapeutics as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Pulmonary Embolism Therapeutics Revenue in 2024
 Figure 17. North America Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Pulmonary Embolism Therapeutics Market Share by Country (2020-2031)
 Figure 19. United States Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Pulmonary Embolism Therapeutics Market Share by Country (2020-2031)
 Figure 23. Germany Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Pulmonary Embolism Therapeutics Market Share by Region (2020-2031)
 Figure 31. China Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Pulmonary Embolism Therapeutics Market Share by Country (2020-2031)
 Figure 39. Mexico Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Pulmonary Embolism Therapeutics Market Share by Country (2020-2031)
 Figure 43. Turkey Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Pulmonary Embolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Boehringer Ingelheim International Revenue Growth Rate in Pulmonary Embolism Therapeutics Business (2020-2025)
 Figure 47. Bristol-Myers Squibb Revenue Growth Rate in Pulmonary Embolism Therapeutics Business (2020-2025)
 Figure 48. Daiichi Sankyo Revenue Growth Rate in Pulmonary Embolism Therapeutics Business (2020-2025)
 Figure 49. F. Hoffmann-La Roche Revenue Growth Rate in Pulmonary Embolism Therapeutics Business (2020-2025)
 Figure 50. Johnson & Johnson Revenue Growth Rate in Pulmonary Embolism Therapeutics Business (2020-2025)
 Figure 51. Bottom-up and Top-down Approaches for This Report
 Figure 52. Data Triangulation
 Figure 53. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Pulmonary Embolism Drug Market Research Report 2025
Venous Thromboembolism Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Thrombolysis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Venous Thromboembolism VTE Devices Market Insights Forecast to 2030
Global Venous Thromboembolism Therapeutics Market Research Report 2025
Global Chronic Thromboembolic Pulmonary Hypertension Market Research Report 2024
Global Venous Thromboembolism Prophylaxis Market Research Report 2025
Medical Consumables for Diagnosis of Interventional Pulmonary Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Pulmonary Hypertension Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COPD Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pulmonary Fibrosis Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Thrombosis Drug Market Research Report 2025
Medical Deep Vein Thrombosis Pumps Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Venous specific Stent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Embolic Filters Market Insights Forecast to 2030
Global Deep Vein Thrombosis DVT Therapy Market Insights Forecast to 2030
Vascular Embolization Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Blood Pressure Management Supplements Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vascular Embolization Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions